Company / Revenue per Share
Dexcom Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$12.12
FY2025
5-year range
$4.97 / $25.48
FY2021-FY2025
Trend
+17.4%
vs FY2024
Sector context
#107 of 153
Health Care
What the data says
At $12.12, Dexcom's revenue per share ranks #107 of 153 in the Health Care sector. Revenue per Share has increased for 3 consecutive years, from $4.97 in FY2022 to $12.12 in FY2025.
Based on SEC 10-K filings.
12.12 in FY2025 with a 5-year CAGR of -9.6%.
Improved from $9.40 to $12.12 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +34.6%
- 5-Year CAGR
- -9.6%
- 10-Year CAGR
- -
Sector benchmark
#107 of 153 in Health CareTop 70% of 153This company $12.12 Sector average $123.89
▼
-90.2% below sector average
Key checks
Key Insights
- Dexcom's revenue per share has grown for 3 consecutive years.
- In FY2025, revenue per share increased 17.4% year-over-year.
- Ranks #107 out of 153 companies in the Health Care sector.
- Peak revenue per share was recorded in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
- Strong return on equity: 26.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $12.12 | +17.4% |
| FY2024 | $10.32 | +9.8% |
| FY2023 | $9.40 | +89.3% |
| FY2022 | $4.97 | -80.5% |
| FY2021 | $25.48 | +27.1% |
| FY2020 | $20.05 | +24.4% |
| FY2019 | $16.11 | +35.9% |
| FY2018 | $11.86 | +604.9% |
| FY2017 | $1.68 | +18.3% |
| FY2016 | $1.42 | +51.0% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026